The possible involvement of trypsin-like enzymes in germination of spores of Bacillus cereus T and Bacillus subtilis 168.
Germination of spores of Bacillus cereus T and Bacillus subtilis 168 was inhibited by the trypsin inhibitors leupeptin and tosyllysine chloromethyl ketone (TLCK) and by the substrates tosylarginine methyl ester (TAME), benzoyl-L-arginine-p-nitroanilide (L-BAPNA) and D-BAPNA. Potencies of these inhibitory compounds were estimated by finding the concentration which inhibited 50% germination (ID50), as measured by events occurring early (loss of heat resistance), at an intermediate stage [dipicolinic acid (DPA) release], and late in germination (decrease in optical density). In B. cereus T, all the compounds inhibited early and late events with the same ID50. In B. subtilis, TAME inhibited early and late events at the same ID50, but all other inhibitors had a lower ID50 for late events than for early events. This suggests that a trypsin-like enzyme activity is involved at two sequential stages in the germination of B. subtilis spores, one occurring at or before the loss of heat resistance and one at or before the decrease in optical density. Different trypsin-like activities were detected in broken dormant spores and germinated spores of B. cereus T and in germinated spores of B. subtilis by means of three chromogenic substrates: benzoyl-L-phenylalanyl-L-valyl-L-arginine-p-nitroanilide (L-PheVA), L-BAPNA and D-BAPNA. Separation of extracts of germinated spores on non-denaturing polyacrylamide gels showed that in both species the substrates were hydrolysed by three distinct enzymes with different electrophoretic mobilities. The three enzymes had different Ki values for the above inhibitors.(ABSTRACT TRUNCATED AT 250 WORDS)
Boschwitz
H
H
Department of Biological Chemistry, Hebrew University of Jerusalem, Israel.
Gofshtein-Gandman
L
L
Halvorson
H O
HO
Keynan
A
A
Milner
Y
Y
D001120:Arginine / Q000031:analogs & derivatives / Q000378:metabolism; D001409:Bacillus cereus / Q000187:drug effects / Q000201:enzymology*; D001412:Bacillus subtilis / Q000187:drug effects / Q000201:enzymology*; D001586:Benzoylarginine Nitroanilide; D002863:Chromogenic Compounds / Q000378:metabolism; D006358:Hot Temperature; D006868:Hydrolysis; D007976:Leupeptins / Q000494:pharmacology; D013171:Spores, Bacterial / Q000187:drug effects / Q000201:enzymology; D014106:Tosylarginine Methyl Ester / Q000494:pharmacology; D014107:Tosyllysine Chloromethyl Ketone / Q000494:pharmacology; D014357:Trypsin / Q000378:metabolism*
D002863:Chromogenic Compounds; D007976:Leupeptins; D014107:Tosyllysine Chloromethyl Ketone; D014106:Tosylarginine Methyl Ester; D001586:Benzoylarginine Nitroanilide; D001120:Arginine; D014357:Trypsin; C032854:leupeptin